Touchlight and Odimma enter cancer therapy clinical material supply agreement

The dbDNA vector technology of Touchlight will be used to support the immunotherapy cancer treatment candidate development.

How smart manufacturing is optimising processes and reducing costs in the pharma supply chain

Tom Lenaerts, head of global process engineering for Datwyler, speaks about smart manufacturing benefits in the pharma supply chain.

Kite and Daiichi Sankyo update cell therapy licensing agreement

According to the revised deal, the companies will transfer the marketing authorisation for Yescarta to Gilead’s Japan subsidiary.

Chemical synthesis: containment challenges for HPAPI handling

Free Webinar Solutions for Handling Nanogram Level Potent Products to Pass Containment Testing Criteria Webinar In this webinar, ILC Dover…

Health Canada approves Novavax’s Covid-19 vaccine for adolescents

The approval was based on findings from the paediatric expansion of the Phase III PREVENT-19 trial of Nuvaxovid.